FindTrial
Sign In

To assess how paralyzing medications are useful in patients admitted to ICU having sudden onset of difficulty in breathing.

A questionnaire-based survey assessing usage of neuromuscular blocking agents in acute respiratory distress patients in ICU - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/01/062072
Enrollment
280
Registered
2024-01-30
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Kasturba Medical College, Manipal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. MBBS Doctors who have finished MD or DM and managing patients in ICU. 2. MBBS Doctors who are in training of MD or DM and working in ICU.

Exclusion criteria

Exclusion criteria: Refusal to give consent

Design outcomes

Primary

MeasureTime frame
To estimate the percentage of usage of neuromuscular blocking agents in patients with moderate-severe ARDS in ICU.Timepoint: at baseline—

Secondary

MeasureTime frame
1. To understand current patterns of neuromuscular blockers utilization by clinicians in patients with moderate to severe acute respiratory distress syndrome. 2. To look for duration of administration & method of dosing & risks associated.Timepoint: at baseline—

Countries

India

Contacts

Public ContactMargiben Tusharbhai Bhatt

Kasturba Medical College, MAHE, Manipal

drmargibhatt@hotmail.com08202922033

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026